ENZYCHEM LIFESCIENCES (183490) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, ENZYCHEM LIFESCIENCES (183490) reported revenue of 67.8 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202567.8 billion KRW-14.3 billion KRW-18.1 billion KRW[source]
202477.4 billion KRW-13.2 billion KRW-22.1 billion KRW[source]
202376.0 billion KRW-14.4 billion KRW-9.4 billion KRW[source]
202226.6 billion KRW-14.7 billion KRW-25.1 billion KRW[source]
202123.0 billion KRW-20.8 billion KRW-27.9 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025144.7 billion KRW6.2 billion KRW138.5 billion KRW[source]
2024177.7 billion KRW15.8 billion KRW161.9 billion KRW[source]
2023205.3 billion KRW11.5 billion KRW193.8 billion KRW[source]
2022246.8 billion KRW45.4 billion KRW201.4 billion KRW[source]
2021132.6 billion KRW58.4 billion KRW74.2 billion KRW[source]

Cash Flow

YearOperatingInvestingFinancingSource
2025-11.0 billion KRW11.9 billion KRW-3.3 billion KRW[source]
2024-574 million KRW7.4 billion KRW-12.1 billion KRW[source]
2023-10.3 billion KRW53.6 billion KRW-35.5 billion KRW[source]
2022-14.3 billion KRW-109.2 billion KRW128.5 billion KRW[source]
2021-18.6 billion KRW-9.7 billion KRW29.3 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice